The cost of Mounjaro without insurance is staggering — roughly $1,000 to $1,100 per month at list price, depending on the pharmacy and dosage. For a medication that many patients need to take indefinitely, the annual expense can exceed $13,000, putting it out of reach for millions of Americans without coverage.
Mounjaro (tirzepatide), manufactured by Eli Lilly, is a dual GIP/GLP-1 receptor agonist approved by the FDA for type 2 diabetes management and, under the brand name Zepbound, for chronic weight management. Its effectiveness has driven enormous demand — and equally enormous conversations about affordability. Here is what you need to know about pricing, savings programs, and alternatives.
Mounjaro List Price Breakdown
Mounjaro is a once-weekly injectable medication available in several dosage strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg). The cost of Mounjaro without insurance at full list price is approximately:
- Monthly supply (4 pens): $1,023 to $1,100
- Three-month supply: $3,069 to $3,300
- Annual cost: $12,276 to $13,200
These figures represent the wholesale acquisition cost (WAC), which is the manufacturer’s list price to wholesalers. Retail pharmacy prices may be slightly higher. Prices are consistent across all dosage strengths — the 2.5 mg starter dose costs the same as the 15 mg maximum dose.
For comparison, here is how Mounjaro’s list price stacks up against other GLP-1 medications:
- Ozempic (semaglutide for diabetes): approximately $935 to $1,000 per month
- Wegovy (semaglutide for weight loss): approximately $1,300 to $1,400 per month
- Zepbound (tirzepatide for weight loss): approximately $1,060 per month (same drug as Mounjaro, different indication)
- Saxenda (liraglutide for weight loss): approximately $1,300 to $1,400 per month
Eli Lilly’s Mounjaro Savings Card
Eli Lilly offers a manufacturer savings card that can substantially reduce the out-of-pocket cost for eligible patients. The details of the program have evolved since launch, but as of early 2026:
- Commercially insured patients: Eligible patients with commercial insurance may pay as little as $25 per month for Mounjaro, with the savings card covering the difference. Eligibility depends on insurance plan participation.
- Uninsured or cash-pay patients: Eli Lilly has offered periodic cash-pay savings programs. Availability and terms change frequently — check mounjaro.com for the most current offers.
The savings card is not available to patients with government insurance (Medicare, Medicaid, Tricare, or VA coverage). The program has a maximum annual benefit, after which patients revert to standard pricing.
Insurance Coverage for Mounjaro
Insurance coverage for Mounjaro varies dramatically depending on the plan, the indication (diabetes vs. weight loss), and the formulary tier:
For type 2 diabetes
Most commercial insurance plans and many Medicare Part D plans cover Mounjaro for type 2 diabetes, though it is often placed on a higher formulary tier (Tier 3 or specialty tier), meaning higher copays. Prior authorization is frequently required, and insurers may require documentation that the patient has tried and failed metformin or other first-line treatments.
For weight loss
Coverage for weight management (under the Zepbound brand) is much more limited. Many commercial plans exclude weight-loss medications, and Medicare Part D does not cover drugs prescribed solely for obesity. Some employers have added anti-obesity medication coverage as a benefit, but this varies widely.
If your insurance denies coverage, your prescribing physician can file an appeal. Appeals succeed more often when supported by clinical documentation showing medical necessity — for example, A1C levels, BMI, comorbid conditions, and prior treatment history.
Ways to Lower Your Mounjaro Cost
If you are facing the full list price, several strategies may help reduce the financial burden:
Pharmacy discount programs
Platforms like GoodRx, RxSaver, and SingleCare sometimes offer discounted pricing for Mounjaro, though savings on brand-name specialty drugs tend to be modest compared to generics. Check current prices at multiple pharmacies — costs can vary by $50 to $200 depending on location.
Patient assistance programs
Eli Lilly’s Lilly Cares Foundation offers free medication to qualifying patients who are uninsured, underinsured, or meet specific income criteria. Applications require documentation of income and insurance status. Visit lillycares.com for details.
Specialty pharmacies and mail-order
Some specialty pharmacies and mail-order services offer slightly lower pricing than retail pharmacies. Your insurer may also require or incentivize use of a preferred specialty pharmacy, which can reduce your copay.
Compounded tirzepatide
Some compounding pharmacies have offered compounded versions of tirzepatide at lower prices. However, the FDA has taken steps to limit compounded GLP-1 drugs, and availability may be restricted. Compounded medications do not undergo the same manufacturing oversight as FDA-approved products, so discuss the risks with your healthcare provider.
Is Mounjaro Worth the Cost?
Clinical trial data for Mounjaro is striking. In the SURMOUNT-1 trial, participants on the highest dose (15 mg) lost an average of 22.5 percent of their body weight over 72 weeks — among the largest weight reductions seen in any pharmaceutical trial for obesity. For type 2 diabetes, the SURPASS clinical trial program showed A1C reductions of up to 2.4 percentage points, according to results published in the New England Journal of Medicine.
These outcomes are clinically meaningful. A 15 to 20 percent reduction in body weight can reverse prediabetes, improve cardiovascular risk factors, reduce sleep apnea severity, and lower the need for other medications. For patients with type 2 diabetes, achieving an A1C below 7 percent reduces the risk of diabetic complications significantly, according to the National Institute of Diabetes and Digestive and Kidney Diseases.
The challenge is that these benefits may require long-term or indefinite use. Research suggests that much of the weight lost is regained within a year of stopping the medication, which makes the ongoing cost a critical factor in treatment decisions.
Mounjaro vs. Ozempic vs. Wegovy: Quick Comparison
All three medications belong to the GLP-1 receptor agonist class, but they differ in important ways:
- Mounjaro (tirzepatide): Dual GIP/GLP-1 agonist. Approved for type 2 diabetes. Weight-loss version sold as Zepbound. Generally shows greater weight loss and A1C reduction in head-to-head trials.
- Ozempic (semaglutide 0.5/1/2 mg): GLP-1 agonist. Approved for type 2 diabetes. Widely used off-label for weight loss. Slightly lower list price than Mounjaro.
- Wegovy (semaglutide 2.4 mg): GLP-1 agonist. Approved specifically for chronic weight management. Higher list price than Ozempic. Also approved for cardiovascular risk reduction in obese adults.
Your prescriber will recommend the best option based on your diagnosis, insurance coverage, and treatment goals. Cost is a legitimate factor in that decision — discuss it openly with your doctor.
Frequently Asked Questions
Can I get Mounjaro for free?
Eli Lilly’s Lilly Cares patient assistance program may provide Mounjaro at no cost to qualifying patients who are uninsured and meet income requirements. The manufacturer savings card can also reduce costs to $25 per month for eligible commercially insured patients.
Does Medicare cover Mounjaro?
Medicare Part D may cover Mounjaro when prescribed for type 2 diabetes, though coverage depends on your specific plan’s formulary. Medicare does not cover Mounjaro or Zepbound when prescribed solely for weight loss. Check with your Part D plan for details.
Will a generic version of Mounjaro become available?
Not in the near term. Eli Lilly holds patents on tirzepatide that extend through the late 2030s. Generic or biosimilar versions are unlikely to reach the market before then, barring patent litigation or regulatory changes.
Is Mounjaro the same as Zepbound?
Yes — both contain tirzepatide as the active ingredient. Mounjaro is FDA-approved for type 2 diabetes, while Zepbound is approved for chronic weight management. The dosing, injection device, and medication are identical; only the brand name and approved indication differ.
Can I use an HSA or FSA to pay for Mounjaro?
Yes. If Mounjaro is prescribed by a licensed healthcare provider, you can use Health Savings Account (HSA) or Flexible Spending Account (FSA) funds to pay for it. This effectively lets you use pre-tax dollars, reducing the real cost by your marginal tax rate.
Know Your Options Before Paying Full Price
The cost of Mounjaro without insurance — roughly $1,000 to $1,100 per month — places it among the most expensive ongoing prescription costs a patient can face. But between manufacturer savings cards, patient assistance programs, insurance appeals, and pharmacy shopping, most patients can significantly reduce what they actually pay.
Start by talking to your prescriber about coverage strategies, apply for the savings card or patient assistance if eligible, and compare prices across pharmacies. If cost remains a barrier, discuss alternative GLP-1 medications with your doctor. For broader guidance on navigating healthcare expenses, explore our healthcare policy guide and our breakdown of how copays work.